- Device
- XIENCE PRIME, XIENCE PRIME SV/LL, XIENCE Xpedition, XIENCE Xpedition SV/LL, XIENCE Alpine, and XIENCE Sierra EVEROLIMUS
- Applicant
- Abbott Vascular
- PMA number
- P110019
- Supplement
- S108
- Product code
- NIQ
- Generic name
- Coronary drug-eluting stent
- Decision date
- 2020-03-19
- Decision code
- APPR
- Date received
- 2019-09-26
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Approval order statement
- Approval for changing the ethylene oxide (EO) sterilization release process for the affected products from the traditional method of biological indicator testing to a parametric release process.